SCOPUS
NEJM Evidence
Massachussetts Medical Society, United States
NEJM Evidence is an academic journal published by Massachussetts Medical Society (United States). Identifiers: eISSN 2766-5526. Indexed in SCOPUS. Metrics: SJR 1.154, SNIP 2.62. tlooto lists 838 papers from this journal.
CiteScore
-
Scopus citation metric
SJR
1.154
SCImago rank
SNIP
2.62
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2766-5526
- Abbreviation
- -
- Publisher
- Massachussetts Medical Society
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2701 Medicine (miscellaneous)3002 Drug Discovery3004 Pharmacology
Papers in this journal
Recent papers
- Measles Outbreak in Cook County, Illinois, September-October 2025.
2026
- Interpreting Evidence with Bayesian Meta-Analysis.
2026
- Seasonal Influenza Activity, Vaccination Rates, and Pediatric Influenza Mortality, Massachusetts 2024-2025.
2026
- Policy Implications of Placebo Bandage for Carpal Tunnel Syndrome.
2026
- Medical Treatment Options in Colorectal Cancer - Expanding the Evidence.
2026
Most cited papers
- Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
2022 · 1,070 citations
- Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.
2022 · 812 citations
- Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
2022 · 299 citations
- Prediction of risk for myeloid malignancy in clonal hematopoiesis
2022 · 245 citations
- Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
2022 · 215 citations